Your browser doesn't support javascript.
loading
RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer.
Deng, Peng; Wang, Zining; Chen, Jinghong; Liu, Shini; Yao, Xiaosai; Liu, Shaoyan; Liu, Lizhen; Yu, Zhaoliang; Huang, Yulin; Xiong, Zhongtang; Xiao, Rong; Gao, Jiuping; Liang, Weiting; Chen, Jieping; Liu, Hui; Hong, Jing Han; Chan, Jason Yongsheng; Guan, Peiyong; Chen, Jianfeng; Wang, Yali; Yin, Jiaxin; Li, Jundong; Zheng, Min; Zhang, Chao; Zhou, Penghui; Kang, Tiebang; Teh, Bin Tean; Yu, Qiang; Zuo, Zhixiang; Jiang, Qingping; Liu, Jihong; Xiong, Ying; Xia, Xiaojun; Tan, Jing.
Afiliación
  • Deng P; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Wang Z; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Chen J; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Liu S; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Yao X; Institute of Molecular and Cell Biology, Singapore.
  • Liu S; The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Liu L; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Yu Z; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Huang Y; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Xiong Z; The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Xiao R; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Gao J; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Liang W; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Chen J; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Liu H; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Hong JH; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.
  • Chan JY; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore.
  • Guan P; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.
  • Chen J; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore.
  • Wang Y; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Yin J; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Li J; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Zheng M; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Zhang C; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Zhou P; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Kang T; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Teh BT; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Yu Q; Institute of Molecular and Cell Biology, Singapore.
  • Zuo Z; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.
  • Jiang Q; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore.
  • Liu J; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore.
  • Xiong Y; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Xia X; SingHealth/Duke-NUS Institute of Precision Medicine, National Heart Centre Singapore, Singapore.
  • Tan J; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.
J Clin Invest ; 132(22)2022 11 15.
Article en En | MEDLINE | ID: mdl-36201246
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Proteínas de Ciclo Celular Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: J Clin Invest Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Proteínas de Ciclo Celular Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: J Clin Invest Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos